Fetal Monitor Signal Board PCBA

8–12 Layer Multi-Channel Signal Acquisition Board for Maternal-Fetal Biophysical Monitoring

Product Overview

The fetal monitor signal board PCBA simultaneously tracks fetal heart rate (FHR), uterine contractions, and maternal vital signs — requiring sensitive, multi-channel biopotential and pressure acquisition on a single PCBA. Our design integrates ultrasound Doppler front-ends with 1 MHz pulse-wave transmission for FHR detection, tocodynamometer strain-gauge amplifiers for contraction monitoring, and maternal ECG/SpO₂ processing channels with cross-channel interference rejection exceeding 90 dB. Advanced autocorrelation algorithms in on-board DSP reliably track beat-to-beat FHR variability even during maternal movement. Manufactured under ISO 13485 with IPC-6012 Class 3 medical standards, these signal boards enhance clinical diagnostic confidence in antepartum and intrapartum care.

Key Specifications

PCBA Assembly Challenges

Assembling a fetal monitor signal board demands meticulous isolation between ultrasound transmission and biopotential reception paths. The 1 MHz ultrasound Doppler transmitter generates excitation pulses up to 50 Vpp — any capacitive coupling to the ECG input traces creates false QRS detections. Careful component placement maintains > 10 mm physical separation between the ultrasound power amplifier and the ECG instrumentation amplifier input stages. The tocodynamometer (toco) strain-gauge amplifier uses a Wheatstone bridge configuration with excitation currents of 5 mA; the bridge completion resistors must be matched to ±0.05% to avoid offset drift during long-duration monitoring sessions. Autocorrelation DSP processors require clean power rails — switching noise from the ultrasound transmitter must be isolated with dedicated LDO regulators and ferrite-bead filtering on every supply domain. Every board undergoes full-channel validation with simulated fetal ECG and contraction patterns.

Test Strategy

Each fetal monitor signal board undergoes comprehensive multi-parameter validation. Ultrasound Doppler channel testing uses calibrated moving-target simulators to verify FHR detection from 50 to 240 BPM with ±1 BPM accuracy. Tocodynamometer channel calibration applies known pressure values (0–100 relative units) to verify linearity within ±3%. Maternal ECG channel characterization verifies QRS detection accuracy with simulated waveforms including baseline wander and muscle artifact. Cross-channel interference testing applies maximum ultrasound drive while measuring noise injection into ECG and toco channels, confirming > 90 dB isolation. 72-hour continuous recording burn-in verifies drift-free operation across all channels with periodic FHR and contraction pattern validation against NIST-traceable fetal simulators.

PCB Manufacturing Difficulty

Fabricating the fetal monitor signal board PCB requires careful management of mixed-signal isolation. The ultrasound transmitter section uses a dedicated ground plane with single-point connection to the system ground to prevent ground-loop noise in biopotential channels. Guard traces surround high-impedance ECG input paths to minimize leakage currents — solder mask registration on guard structures must be within ±2 mil. The toco amplifier bridge circuit requires controlled impedance paths with symmetric routing to maintain common-mode rejection. Finished boards undergo 100% automated optical inspection, isolation-resistance testing between ultrasound and ECG domains (> 100 MΩ at 500 V DC), and ionic contamination testing below 1.56 µg/cm² NaCl equivalent per IPC-6012 Class 3 before release to assembly.

More information